Advances in Retinopathy of Prematurity / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
;
(6): 261-266, 2019.
Artigo
em Chinês
| WPRIM
| ID: wpr-776040
ABSTRACT
Retinopathy of prematurity(ROP)is a pathological neovascularization with fibrotic changes in the fundus of premature infants.It is a major cause of preventable blindness in children in both developing and developed countries.Treatment of ROP has long been a hot research topic in ophthalmology and pediatrics.With a clearer knowledge of the pathogenesis of ROP,more basic and clinical studies have been carried out.The anti-vascular endothelial growth factor therapy and surgical treatment have become mature strategies,and a variety of therapeutic drugs including insulin-like growth factor-1,transforming growth factor-β,polyunsaturated fatty acids,and β-adrenergic receptor blockers have been developed.This article reviews the recent advances in ROP.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Cirurgia Geral
/
Terapêutica
/
Retinopatia da Prematuridade
/
Recém-Nascido Prematuro
/
Fator A de Crescimento do Endotélio Vascular
/
Tratamento Farmacológico
/
Neovascularização Patológica
Limite:
Criança
/
Humanos
/
Recém-Nascido
Idioma:
Chinês
Revista:
Acta Academiae Medicinae Sinicae
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS